SESSION I
The session opened with two papers related to the problems of carrier detection in Duchenne dystrophy. Percy et al. presented further data using logistic discrimination as a means of increasing the value of results from multiple tests in carrier detection. The data clearly bore out the previously reported enhancement by this statistical discriminatory method as applied to series of individual tests. It was pointed out by the authors that positive detection of normals (in the population at risk) was of equal importance. Barber et al. discussed a new approach to heterozygote detection using cloned fibroblasts. Although their initial results did not show obvious differences between heterozygotes and normals, the technique clearly has potential importance.
The use of cloned human cells also figured strongly in other presentations. For example, Askanis beautifully illustrated the use of tissue culture for Schwann cells in various human neuropathies. The possibility that Wrogemann et al. may have demonstrated a gene product in Duchenne dystrophy cultured fibroblasts by two-dimensional gel electrophoresis raised considerable interest. Although these authors were able to supply a rough molecular weight for the "disappearing" protein (i.e. not present in normal fibroblasts), this will require more detailed study before the importance of the discovery can be assessed.
Increased interest is being shown by researchers in myotonic dystrophy. This partly stems from the relative frequency with which this disease is seen and is now, in some parts of the country, the most common type of dystrophy. Banerjee et al. reported a study on the causes of the hypercatabolic reduction of IgG in this dystrophy, and proposed the hypothesis that the low affinity of the Fc protector receptors in monocytes could account for the consumption of IgG. Belanger and McComas described a meticulous study of the dorsiflexors and plantifiexors in dystrophic patients and showed how effective the combined clinical and electrophysiological observations can be in providing base data for follow-up purposes. This should provide a model for those concerned with detailed recording of clinical findings.
Myasthenia gravis still retains a number of problem areas, but perhaps the most cogent are those that relate to management. Humphrey and St. George-Hyslop were able to show convincingly the importance of persistent immunosuppression in the management of myasthenia and obtained a significant reduction in relapse rate and clinical severity in those patients treated with azathioprine. Quastel and Pennefather reported data which permits a more quantitative assessment of receptor dysfunction in this disease.
The first session concluded with a description of a springloaded knee joint orthosis for Duchenne muscular dystrophy patients. While this certainly provides for a more stable knee joint allowing knee flexion the mechanism is still far from perfect and clearly requires more work before it can be of general value.
At the conclusion of the platform presentations a series of poster demonstrations were held. Some of these represented elaborations of platform papers. For example, a poster was presented by Belanger and Quintan on muscle testing. St. George-Hyslop and Humphrey presented anti-AChR antibody titre correlations with clinical status in myasthenia gravis indicating that over a long term this correlation was not close.
The remaining poster presentations covered a relatively wide field from tissue culture to clinical assessment of structural spinal deformities in Duchenne dystrophy. While all these poster presentations had a worthwhile message as is indicated in their description in the abstracts, particular men- Thompson et al. in studying diagnostic needle muscle biopsies appears to be a valuable contribution to the methodology that can be applied to the study of muscle in the clinic. While the results presented were preliminary, it is quite clear that a lot more is going to be heard of this technique. The method of assessment of degrees of spinal deformity established as an ongoing project at The Hospital for Sick Children by Yoneda and others is important in the management and prevention of the distressing spinal distortions that can occur not only in muscular dystrophy, but in other neuromuscular diseases in which paraspinal muscles are weak. This group now has enough experience in the application of the method to the assessment of spinal deformities that a nationwide application of the method through The Hospital for Sick Children is being encouraged.
SESSION II
A number of abnormalities in muscle biochemistry, physiology and morphology were described for murine, avian and hamster models of dystrophy in the second session. Developmental changes and properties of limb muscles in adult mice (Bressler et al; Parry) and wing muscles of chickens (Gandy et al; Hoekman et al.) indicated that there is an apparent lack of nerve-induced differentiation of slow and fast skeletal muscles in dystrophy. The most striking physiological change in the affected muscles, besides a progressive weakness, is a decreased rate of relaxation after twitch or tetanic contractions, which may be due to a slower reabsorption of calcium ions by the sarcoplasmic reticulum (Gordon and Stein) . Histochemically, the fibre distribution appears to move selectively to a greater proportion of fast oxidative fibres (Ovalle et al; Parry) . Some of these changes, as well as changes in physiological properties may be associated with the severely altered patterns of activation of the limb muscles in dystrophic mice as a result of the lack of Schwann cell ensheathment in the lumbosacral roots (Bray et al.) .
Activity patterns in dystrophic animals were implicated also in the necrotic changes occurring in the muscles, since necrosis could be completely halted in young dystrophic hamsters by cord transection (Karpati et al). Abnormal thymic function was also implicated in the genesis of the dystrophic process and in the degenerative changes occurring in the muscles. Potworowski & Lemieux described preliminary findings of depressed immune reactivity in murine dystrophy due to abnormal thymic function. Dystrophic mice showed depressed reactivity to antibodies raised in culture to thymic epithelial antigens, either with or without exogenous thymic hormone. The thymus also showed abnormal levels of mast cells and contained histamine in murine and avian dystrophy. Levels of histamine and mast cells were significantly raised in muscle. The changes in these levels in muscle and thymus were progressive with age and were suggested to be important in the progressive degeneration in muscle (Befus and Nielson).
Jasch described changes in proportions of myosin light chains but these did not appear to significantly alter the rate of rise of tension. The normal temperature dependence of dystrophic muscle suggested that defects in contractile proteins did not underly changes in contractile speed. Rather, alterations in calcium pumping, perhaps secondary to calcium loading, may account for the decreased rate of relaxation in dystrophic muscles (Gordon and Stein) .
Changes in protein synthesis in dystrophic muscles are progressive with age. Significant alterations in protein synthesis was evident from reduction in activity of polysomes in dystrophic hamsters (Brakier-Gingras and Jolicoeur), alterations in acetylcholinesterase isozyme content and distribution (Lindenbaum and Livett; Gisiger and Stephens), reduction in synthesis of alpha-actinin and other Z-line proteins and a later decline in synthesis of myofibrillar proteins (Atkinson et al.) . High voltage electron microscopy is currently being used by the group in London (Shivers et al.) to visualize the spatial arrangement of alpha-actinin, and contractile proteins to determine the anchoring of actin filaments at the Z-line in the normal and the dystrophic muscle. Alpha-actinin was also implicated in the decline in intramembrane particles distributed in plasma membranes (Graham et al.) .
The mouse model of dystrophy differs from other animal models and from the human dystrophy in the abnormal axonal ensheathment of the lumbosacral spinal roots. Bray et al. provided evidence that the location of the dystrophic abnormality in the axons was not the exclusive mechanism responsible for poor axonal ensheathment, because regenerating axons after crush injury became normally ensheathed. Abnormalities may therefore be a function of time rather than locality. Evidence was also presented to show that uptake and/or transport of nerve growth factor in sciatic nerves of dystrophic mice was significantly less than normal (Rutherford and Boegman).
The second session also included a special guest lecture by Dr. Stanley Appel. Appel is Chairman of Neurology and Director of the Jerry Lewis Neuromuscular Research Center at Baylor University in Houston. He is well known for his outstanding biochemical work on a variety of nerve and muscle diseases. Appel spoke on growth factors which influence the increase in size of motor cell bodies in the spinal cord and the elongation of their nerve fibres to the periphery. Growth factors are proteins which can be isolated from muscles, sense organs and Schwann cells. Attention was focused on the role of growth factors in amyothrophic lateral sclerosis (A.L.S.).
SESSION HI
The third session dealt with the properties of normal and atrophic muscles. Muscles undergo atrophic changes when they are disconnected from their nerve fibres (denervated), as well as in various other disease states. When electrically stimulated, the time course of the contractile events is slowed (Webster and Bressler) and the reabsorption of calcium ions is reduced in denervated muscles (Boegman and Wan), as in dystrophic muscles.
Davis demonstrated that an extract of nerve, when injected daily, could prevent some components of the atrophy in muscles subjected to denervation. Thus, nerves contain growth factors which are important for the maintenance of normal muscle properties, in addition to the growth factors described by Appel, which can be isolated from muscle and affect nerve growth.
The interaction of nerve and muscle in normal growth and development, as well as in disease processes, is an exciting research area which should provide new possibilities for treatment of nerve and muscle diseases in the future. These processes can be studied in a wide variety of animals including lobsters (Govind) and chickens (Bloom and Cosmos; Butler et al; Steele) . A particularly interesting method for studying these interactions is by producing chimaeras (organisms formed by grafting differing genetic information) from different species such as chick and quail (Beresford et al.) or genetically different strains of the same species such as the mouse (Peterson and Cross). In this type of experiment the influence of genetically normal nerves on diseased muscles can be studied and vice-versa.
Several papers in this session dealt with normal muscles and reported further evidence on the interactions of muscle proteins (Cote et al.) , the limiting rate constants in muscular contraction (Stein et al.) , the regulation of glucose transport (Klip et al.) , the structure of muscle calsequestrin (Reithmeier and Cozens) and the function of the sarcoplasmic reticulum (MacLennan et al.) . Interestingly, development of the sarcoplasmic reticulum, which absorbs calcium ions from the muscle cytoplasm, is inhibited in the absence of spontaneous contractions of cultured skeletal muscle cells (Charuk and Holland). In contrast, defects in dystrophic muscle membranes may lead to calcium loading, and Carpenter and Karpati have developed a micro-puncture technique to simulate such defects. Finally, several papers dealt with the effects on normal neuromuscular function of age (Vandervoort et al.), bodybuilding (MacDougall et al.) and fatigue (Hunter et al.) .
SESSION IV
The session opened with a presentation in which Szewczuk described an abnormal immune response in dystrophic mice when injected with a thymic-dependent antigen. Since this change in thymic function was age-related, defective maturation of the thymus may be involved in the progression of muscular dystrophy. Slonecker et al. showed, using whole thymic transplants from dystrophic mice, that hormonal interactions with the thymus may influence the development of dystrophic traits.
Two papers from Pena's laboratory suggested that aggregation of intermediate filaments in cultured human skin fibroblasts caused by neurotoxins such as 2,5 hexanedione or acrylamide strongly resemble the aggregation observed in giant axonal neuropathy. This aggregation is not due to an alteration in vimentin, the major protein of intermediate filaments and suggests that a regulatory protein involved in the organization of intermediate filaments may be involved.
Lectins are useful in detecting alterations in cell surface carbohydrate. These probes in conjunction with a sensitive visualization technique and transfer of proteins from polyacrylamide gels to nitro-cellulose paper have been used by Gordon et al. to examine differences between the cell surface carbohydrate in normal and dystrophic cells. Lectins can also be used to visualize membrane oligosaccharides in thin sections of muscle. Parfett et al. illustrated the role of cell surface carbohydrate in muscle development and found that myoblasts resistant to the lectin Concanavalin A failed to fuse.
Poznansky et al. found that alterations in the membrane fluidity of squid axon, as a result of changes in cholesterol level, had no effect on sodium or potassium currents. Cholesterol in the plasma membrane of axons was found to move from one side of the bilayer to the other with a half time of about 10 minutes. Logan et al. showed that proline uptake into muscle cells in culture was stimulated by calcium as well as by sodium.
Creatine kinase is a useful marker enzyme for certain types of muscular dystrophy. Guslits and Jacobs using highly resolving gel systems showed that up to 21 active enzyme subspecies could be detected in extracts of human skeletal muscle. The ability to resolve the subforms of creatine kinase may provide a powerful diagnostic tool for muscle disorders. Kreis et al. showed that isolation of the defective gene of Duchenne Muscular Dystrophy is now possible using powerful recombinant DNA methodology.
Pollack et al. showed by indirect immunofluorescence that the components of the cytoskeleton of fibroblasts from dystrophic hamster fibroblasts had a normal cellular distribution. The tubulin and high molecular weight microtubuleassociated proteins could be visualized using a sensitive Gold immunolabelling procedure (Stearns and Ochs).
Heat shock treatment of cells can result in alterations in the activity of specific genes. J. Bag found that heat shock treatment of muscle cells in culture resulted in the production of several new polypeptides with weights of 25,000, 65,000 and 81,000 daltons, while the synthesis of some normal cellular proteins including those of the cytoskeleton were decreased. A similar treatment of fibroblasts from normal and dystrophic hamsters also showed an increased synthesis of 25,000 and 64,000 dalton proteins (Pollack et al.) . Cates and Holland showed that a 70,000 dalton cell surface protein could be detected on the cell surface of cultured chick skeletal muscle cells by the inability of antibody preabsorbed with intact cells to bind to this cell surface component.
Else and Barth have localized a Ca2+-dependent protease to the plasma membrane of muscle cells using indrect immunofluorescence. Inhibition of these Ca 2+ -dependent proteases by thiol reagents results in less damage to muscle cells (Jasmin and Proschek).
The finding that a protein kinase from muscle cells binds mRNA suggests that this protein may play a regulatory role in muscle development (Sell et al.) . The level of protein initiation was decreased in all tissues (from dystrophic mice) examined by Nicholls and Nickson. This was due to a decrease in the activity of initiation factor elF-2. A decrease in the snythetic activity of polysomes isolated from dystrophic heart muscle was suggested by Bakier-Gingras and Jolicoeur to be due to a defect in the ribosome itself.
A highlight of the final session was a guest lecture by King Engel, who is Professor of Neurology and Director of the Center for Neuromuscular Diseases at the University of Southern California in Los Angeles. Engel is well known for his innovative treatments of various neuromuscular diseases, as well as his anatomical slides illustrating the nature of the disorders at the cellular level. Those present at the workshop were treated to a review of the pathogenesis and treatment of neuromuscular diseases, which was impressive in terms of the sheer beauty of the illustrations, as well as the scope of the knowledge they represented.
Also in the final session, John Connors (executive director of MDAC) showed a videotape that the Association has recently made with the help of Access television in Alberta on the treatment of muscular dystrophy. Groups interested in obtaining a copy of this tape should contact Mr. Connors. MDAC should also be congratulated on its continuing support of these scientific workshops. Ideas generated in a few minutes of discussion at these meetings can lead to projects that may take years to complete in the laboratory, but can have important implications for the treatment of neuromuscular diseases. Many people left the meeting feeling that real progress had been made since the last workshop in Hamilton two years ago, and that there is tremendous hope for the future.
